NEVVI Medicare utilization intelligence

← back

REHMAN, NADIAMD NPI 1821238783 Clinician

Internal Medicine · PEORIA, IL

Specialty Internal Medicine — from billed Medicare claims
Trained MEDICAL COLLEGE OF WISCONSIN — medical school, self-reported to CMS
In practice about 19 years since medical school (class of 2007, self-reported to CMS)
Location PEORIA, IL · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 87 codes billed · 182,263 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
ONCOLOGY-HEMATOLOGY ASSOCIATES OF CENTRAL ILLINOIS P C
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2026-03

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J9299 Injection, nivolumab, 1 mg
J9263 Injection, oxaliplatin, 0.5 mg
J9271 Injection, pembrolizumab, 1 mg
J9267 Injection, paclitaxel, 1 mg
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J9025 Injection, azacitidine, 1 mg
J0897 Injection, denosumab, 1 mg
J0185 Injection, aprepitant, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1437 Injection, ferric derisomaltose, 10 mg
J2469 Injection, palonosetron hcl, 25 mcg
J0461 Injection, atropine sulfate, 0.01 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J3475 Injection, magnesium sulfate, per 500 mg
36415 Insertion of needle into vein for collection of blood sample
80053 Blood test, comprehensive group of blood chemicals
J0640 Injection, leucovorin calcium, per 50 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J9190 Injection, fluorouracil, 500 mg
96413 Administration of chemotherapy into vein, 1 hour or less
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J3480 Injection, potassium chloride, per 2 meq
J9206 Injection, irinotecan, 20 mg
J1750 Injection, iron dextran, 50 mg
96375 Injection of additional new drug or substance into vein
83521 Measurement of immunoglobulin light chains
96372 Injection of drug or substance under skin or into muscle
J2405 Injection, ondansetron hydrochloride, per 1 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
71260 Ct scan of chest with contrast
83735 Magnesium level
J3489 Injection, zoledronic acid, 1 mg
82784 Gammaglobulin (immune system protein) measurement
83540 Iron level
83550 Iron binding capacity
82728 Ferritin (blood protein) level
J9045 Injection, carboplatin, 50 mg
74177 Ct scan of abdomen and pelvis with contrast
82306 Vitamin d-3 level
84100 Phosphate level
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
84165 Protein measurement, serum
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
J1200 Injection, diphenhydramine hcl, up to 50 mg
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96415 Administration of chemotherapy into vein, each additional hour
86334 Immunologic analysis technique on serum (immunofixation)
96417 Administration of additional new drug or substance into vein, 1 hour or less
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
83615 Lactate dehydrogenase (enzyme) level
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
J3490 Unclassified drugs
96374 Injection of drug or substance into vein
82607 Cyanocobalamin (vitamin b-12) level
84443 Blood test, thyroid stimulating hormone (tsh)
96523 Irrigation of implanted venous access drug delivery device
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
96360 Infusion into a vein for hydration, 31-60 minutes
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
84439 Thyroxine (thyroid chemical), free
J7030 Infusion, normal saline solution , 1000 cc
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
82533 Cortisol (hormone) measurement, total
85045 Red blood count, automated test
82746 Folic acid level, serum
82378 Carcinoembryonic antigen (cea) protein level
96361 Infusion into a vein for hydration, each additional hour
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
84153 Psa (prostate specific antigen) measurement, total
71250 Ct scan of chest without contrast
76497 Other ct scan
80048 Blood test, basic group of blood chemicals (calcium, total)
83010 Haptoglobin (serum protein) level
99442 Telephone medical discussion with physician, 11-20 minutes
70491 Ct scan of soft tissue of neck with contrast
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
77080 Dxa bone density measurement of hip, pelvis, spine
82565 Blood creatinine level
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.